Stephen Morlock, Director at BioPharmX Corp (BPMX), bought 5,000 shares at $1.25 ($6K) on 2015-10-14, disclosed to the SEC on 2015-10-15.
Open-market purchase of $6k BPMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.25 | 2,000 | $3K | 40.4% |
| 2 | $1.23 | 3,000 | $4K | 59.6% |
| Total | $1.24 avg | 5,000 | $6K | 100% |
| Filing → |
| BPMX | BUY | 2016-11-29 | $150K | — | Filing → |
| BPMX | BUY | 2016-01-15 | $18K | — | Filing → |
| BPMX | BUY | 2016-01-12 | $9K | — | Filing → |